Suppr超能文献

[结核性胸膜炎患者综合治疗中的致病因素]

[Pathogenetic agents in the complex treatment of patients with tuberculous pleurisy].

作者信息

Tsymbalar' G G, Tudos T P, Zhurzha L E

出版信息

Probl Tuberk. 1989(4):23-7.

PMID:2660130
Abstract

Data on therapy of 257 patients with tuberculous pleurisy and the clinicoroentgenological outcomes at the hospitalization stage were studied. 180 of them were treated pathogenetically in addition to the use of etiotropic drugs. The pathogenetic treatment included the use of prednisolone, tuberculin, pyrogenal, phonophoresis or electrophoresis with heparin. For estimating the therapy efficiency x-ray criteria of the size of residual pleural lesions after exudate resolution were developed. It was shown that inclusion of the pathogenetic treatment into combined therapy of the patients with tuberculous pleurisy markedly increased its efficiency and led to more favourable clinicoroentgenological outcomes. The results were especially favourable with tuberculin and successive application of the pathogenetic treatment corresponding to the process phase.

摘要

对257例结核性胸膜炎患者的治疗数据以及住院阶段的临床-放射学结果进行了研究。其中180例除使用病因特异性药物外,还进行了发病机制治疗。发病机制治疗包括使用泼尼松龙、结核菌素、热原质、超声透入疗法或肝素电泳。为评估治疗效果,制定了渗出液消退后残留胸膜病变大小的X线标准。结果表明,在结核性胸膜炎患者的联合治疗中加入发病机制治疗可显著提高其疗效,并带来更有利的临床-放射学结果。使用结核菌素以及根据病程阶段连续应用发病机制治疗的结果尤其良好。

相似文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验